Cisco (CSCO) Q2 earnings report 2025

Cisco (CSCO) Q2 earnings report 2025

Cisco CEO Chuck Robbins speaking on CNBC’s “Squawk Box” outside the World Economic Forum in Davos, Switzerland, on Jan. 22, 2025. Gerry Miller | CNBC Cisco shares climbed about 6% in extended trading on Wednesday after the networking hardware maker reported fiscal second-quarter results and guidance that topped Wall Street’s expectations. Here’s how the company…

Read More
JPMorgan says Super Micro is still a sell despite company’s lofty outlook

JPMorgan says Super Micro is still a sell despite company’s lofty outlook

Super Micro Computer issued a lofty fiscal 2026 outlook, lifting the stock more than 13%. JPMorgan remains skeptical, however. The company said it expects revenue to reach $40 billion in fiscal 2026, overshadowing a much more tepid near-term forecast. Super Micro issued fiscal 2025 revenue guidance ranging between $23.5 billion and $25 billion, while analysts…

Read More
Biogen (BIIB) earnings Q4 2024

Biogen (BIIB) earnings Q4 2024

A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Wednesday posted fourth-quarter revenue and profit that topped expectations as its cost cuts showed progress and new products, including its breakthrough Alzheimer’s treatment Leqembi, saw growth.  But the biotech company’s…

Read More
JPMorgan upgrades this beaten-down industrial salt stock, says it’s primed for a major turnaround

JPMorgan upgrades this beaten-down industrial salt stock, says it’s primed for a major turnaround

Compass Minerals could be a winner from this year’s cold winter, per JPMorgan. Analyst Jeffrey Zekauskas upgraded the stock to overweight from neutral. He also raised his target price by $2 to $15 per share, which suggests 25.3% upside potential from Tuesday’s close. Compass Minerals has struggled of late, with multiple “business dislocations that have…

Read More
CVS Health (CVS) earnings Q4 2024

CVS Health (CVS) earnings Q4 2024

An exterior view of a CVS pharmacy in Danville, Pennsylvania.  Paul Weaver | Lightrocket | Getty Images CVS Health on Wednesday reported fourth-quarter revenue and profit that topped estimates, even as its troubled insurance business continued to see higher medical costs.  The company also issued a full-year 2025 adjusted earnings outlook of $5.75 to $6…

Read More
Coca-Cola (KO) Q4 2024 earnings

Coca-Cola (KO) Q4 2024 earnings

James Quincey, CEO of Coca-Cola, speaking on CNBC’s “Squawk Box” outside of the World Economic Forum in Davos, Switzerland, on Jan. 22, 2025. Gerry Miller | CNBC Coca-Cola on Tuesday reported quarterly earnings and revenue that topped analysts’ expectations, fueled by a global rise in demand for its drinks. Shares of the company rose 2%…

Read More
Back To Top